NAIROBI/DAKAR, Oct 6 (Reuters) - The World Health
Organization (WHO) said on Wednesday the only approved vaccine
against malaria should be widely used on African children,
potentially a major advance against a disease that kills
hundreds of thousands of people annually.
The recommendation is for RTS,S, or Mosquirix, a vaccine
developed by British drugmaker GlaxoSmithKline. It was
jointly announced in Geneva by the WHO's top advisory bodies for
malaria and immunization, the Malaria Policy Advisory Group and
the Strategic Advisory Group of Experts on Immunisation.
(Reporting by Maggie Fick and Aaron Ross; Editing by Katharine
Houreld and Mark Potter)